Hegewald Janice, Wegewitz Uta E, Euler Ulrike, van Dijk Jaap L, Adams Jenny, Fishta Alba, Heinrich Philipp, Seidler Andreas
Institute and Policlinic of Occupational and Social Medicine, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, Dresden, Germany, 01307.
Cochrane Database Syst Rev. 2019 Mar 14;3(3):CD010748. doi: 10.1002/14651858.CD010748.pub2.
People with coronary heart disease (CHD) often require prolonged absences from work to convalesce after acute disease events like myocardial infarctions (MI) or revascularisation procedures such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Reduced functional capacity and anxiety due to CHD may further delay or prevent return to work.
To assess the effects of person- and work-directed interventions aimed at enhancing return to work in patients with coronary heart disease compared to usual care or no intervention.
We searched the databases CENTRAL, MEDLINE, Embase, PsycINFO, NIOSHTIC, NIOSHTIC-2, HSELINE, CISDOC, and LILACS through 11 October 2018. We also searched the US National Library of Medicine registry, clinicaltrials.gov, to identify ongoing studies.
We included randomised controlled trials (RCTs) examining return to work among people with CHD who were provided either an intervention or usual care. Selected studies included only people treated for MI or who had undergone either a CABG or PCI. At least 80% of the study population should have been working prior to the CHD and not at the time of the trial, or study authors had to have considered a return-to-work subgroup. We included studies in all languages. Two review authors independently selected the studies and consulted a third review author to resolve disagreements.
Two review authors extracted data and independently assessed the risk of bias. We conducted meta-analyses of rates of return to work and time until return to work. We considered the secondary outcomes, health-related quality of life and adverse events among studies where at least 80% of study participants were eligible to return to work.
We found 39 RCTs (including one cluster- and four three-armed RCTs). We included the return-to-work results of 34 studies in the meta-analyses.Person-directed, psychological counselling versus usual careWe included 11 studies considering return to work following psychological interventions among a subgroup of 615 participants in the meta-analysis. Most interventions used some form of counselling to address participants' disease-related anxieties and provided information on the causes and course of CHD to dispel misconceptions. We do not know if these interventions increase return to work up to six months (risk ratio (RR) 1.08, 95% confidence interval (CI) 0.84 to 1.40; six studies; very low-certainty evidence) or at six to 12 months (RR 1.24, 95% CI 0.95 to 1.63; seven studies; very low-certainty evidence). We also do not know if psychological interventions shorten the time until return to work. Psychological interventions may have little or no effect on the proportion of participants working between one and five years (RR 1.09, 95% CI 0.88 to 1.34; three studies; low-certainty evidence).Person-directed, work-directed counselling versus usual careFour studies examined work-directed counselling. These counselling interventions included advising patients when to return to work based on treadmill testing or extended counselling to include co-workers' fears and misconceptions regarding CHD. Work-directed counselling may result in little to no difference in the mean difference (MD) in days until return to work (MD -7.52 days, 95% CI -20.07 to 5.03 days; four studies; low-certainty evidence). Work-directed counselling probably results in little to no difference in cardiac deaths (RR 1.00, 95% CI 0.19 to 5.39; two studies; moderate-certainty evidence).Person-directed, physical conditioning interventions versus usual careNine studies examined the impact of exercise programmes. Compared to usual care, we do not know if physical interventions increase return to work up to six months (RR 1.17, 95% CI 0.97 to 1.41; four studies; very low-certainty evidence). Physical conditioning interventions may result in little to no difference in return-to-work rates at six to 12 months (RR 1.09, 95% CI 0.99 to 1.20; five studies; low-certainty evidence), and may also result in little to no difference on the rates of patients working after one year (RR 1.04, 95% CI 0.82 to 1.30; two studies; low-certainty evidence). Physical conditioning interventions may result in little to no difference in the time needed to return to work (MD -7.86 days, 95% CI -29.46 to 13.74 days; four studies; low-certainty evidence). Physical conditioning interventions probably do not increase cardiac death rates (RR 1.00, 95% CI 0.35 to 2.80; two studies; moderate-certainty evidence).Person-directed, combined interventions versus usual careWe included 13 studies considering return to work following combined interventions in the meta-analysis. Combined cardiac rehabilitation programmes may have increased return to work up to six months (RR 1.56, 95% CI 1.23 to 1.98; number needed to treat for an additional beneficial outcome (NNTB) 5; four studies; low-certainty evidence), and may have little to no difference on return-to-work rates at six to 12 months' follow-up (RR 1.06, 95% CI 1.00 to 1.13; 10 studies; low-certainty evidence). We do not know if combined interventions increased the proportions of participants working between one and five years (RR 1.14, 95% CI 0.96 to 1.37; six studies; very low-certainty evidence) or at five years (RR 1.09, 95% CI 0.86 to 1.38; four studies; very low-certainty evidence). Combined interventions probably shortened the time needed until return to work (MD -40.77, 95% CI -67.19 to -14.35; two studies; moderate-certainty evidence). Combining interventions probably results in little to no difference in reinfarctions (RR 0.56, 95% CI 0.23 to 1.40; three studies; moderate-certainty evidence).Work-directed, interventionsWe found no studies exclusively examining strictly work-directed interventions at the workplace.
AUTHORS' CONCLUSIONS: Combined interventions may increase return to work up to six months and probably reduce the time away from work. Otherwise, we found no evidence of either a beneficial or harmful effect of person-directed interventions. The certainty of the evidence for the various interventions and outcomes ranged from very low to moderate. Return to work was typically a secondary outcome of the studies, and as such, the results pertaining to return to work were often poorly reported. Adhering to RCT reporting guidelines could greatly improve the evidence of future research. A research gap exists regarding controlled trials of work-directed interventions, health-related quality of life within the return-to-work process, and adverse effects.
冠心病(CHD)患者在经历急性疾病事件(如心肌梗死(MI))或血管重建手术(如冠状动脉搭桥术(CABG)或经皮冠状动脉介入治疗(PCI))后,通常需要长时间休假以康复。冠心病导致的功能能力下降和焦虑可能会进一步延迟或阻碍患者重返工作岗位。
评估针对个人和工作的干预措施对冠心病患者重返工作岗位的影响,并与常规护理或不进行干预进行比较。
我们检索了截至2018年10月11日的CENTRAL、MEDLINE、Embase、PsycINFO、NIOSHTIC、NIOSHTIC - 2、HSELINE、CISDOC和LILACS数据库。我们还检索了美国国立医学图书馆注册库clinicaltrials.gov,以识别正在进行的研究。
我们纳入了随机对照试验(RCT),这些试验研究了接受干预或常规护理的冠心病患者的重返工作情况。选定的研究仅包括接受过MI治疗或接受过CABG或PCI的患者。至少80%的研究人群在患冠心病之前应已工作,而在试验时不应工作,或者研究作者必须考虑重返工作亚组。我们纳入了所有语言的研究。两位综述作者独立选择研究,并咨询第三位综述作者以解决分歧。
两位综述作者提取数据并独立评估偏倚风险。我们对重返工作率和直至重返工作的时间进行了荟萃分析。对于至少80%的研究参与者有资格重返工作的研究,我们考虑了次要结局、健康相关生活质量和不良事件。
我们找到了39项RCT(包括1项整群RCT和四项三臂RCT)。我们在荟萃分析中纳入了34项研究的重返工作结果。
针对个人的心理咨询与常规护理
我们在荟萃分析中纳入了11项研究,这些研究考虑了615名参与者亚组中心理干预后的重返工作情况。大多数干预措施采用某种形式的咨询来解决参与者与疾病相关的焦虑,并提供有关冠心病病因和病程的信息以消除误解。我们不知道这些干预措施在六个月内是否能提高重返工作率(风险比(RR)1.08,95%置信区间(CI)0.84至1.40;六项研究;极低确定性证据)或在六至十二个月内是否能提高重返工作率(RR 1.24,95%CI 0.95至1.63;七项研究;极低确定性证据)。我们也不知道心理干预是否能缩短直至重返工作的时间。心理干预对一至五年内工作的参与者比例可能几乎没有影响(RR 1.09,95%CI 0.88至1.34;三项研究;低确定性证据)。
针对个人的工作指导咨询与常规护理
四项研究考察了工作指导咨询。这些咨询干预措施包括根据跑步机测试为患者提供何时重返工作的建议,或进行扩展咨询以包括同事对冠心病的恐惧和误解。工作指导咨询可能在直至重返工作的天数平均差异(MD)方面几乎没有差异(MD -7.52天,95%CI -20.07至5.03天;四项研究;低确定性证据)。工作指导咨询可能在心脏死亡方面几乎没有差异(RR 1.00,95%CI 0.19至5.39;两项研究;中度确定性证据)。
针对个人的身体锻炼干预与常规护理
九项研究考察了运动计划的影响。与常规护理相比,我们不知道身体干预在六个月内是否能提高重返工作率(RR 1.17,95%CI 0.97至1.41;四项研究;极低确定性证据)。身体锻炼干预在六至十二个月的重返工作率方面可能几乎没有差异(RR 1.09,95%CI 0.99至1.20;五项研究;低确定性证据),并且在一年后工作的患者比例方面可能也几乎没有差异(RR 1.04,95%CI 0.82至1.30;两项研究;低确定性证据)。身体锻炼干预在重返工作所需时间方面可能几乎没有差异(MD -7.86天,95%CI -29.46至13.74天;四项研究;低确定性证据)。身体锻炼干预可能不会增加心脏死亡率(RR 1.00,95%CI 0.35至2.80;两项研究;中度确定性证据)。
针对个人的综合干预与常规护理
我们在荟萃分析中纳入了13项研究,这些研究考虑了综合干预后的重返工作情况。综合心脏康复计划可能在六个月内提高重返工作率(RR 1.56,95%CI 1.23至1.98;额外有益结果的治疗所需人数(NNTB)5;四项研究;低确定性证据),并且在六个月至十二个月的随访中重返工作率可能几乎没有差异(RR 1.06,95%CI 1.00至1.13;10项研究;低确定性证据)。我们不知道综合干预是否增加了一至五年内工作的参与者比例(RR 1.14,95%CI 0.96至1.37;六项研究;极低确定性证据)或五年内工作的参与者比例(RR 1.09,95%CI 0.86至1.38;四项研究;极低确定性证据)。综合干预可能缩短了直至重返工作所需的时间(MD -40.77,95%CI -67.19至 -14.35;两项研究;中度确定性证据)。综合干预在再梗死方面可能几乎没有差异(RR 0.56,95%CI 0.23至1.40;三项研究;中度确定性证据)。
针对工作的干预措施
我们未找到专门研究工作场所严格针对工作的干预措施的研究。
综合干预可能在六个月内提高重返工作率,并可能减少缺勤时间。否则,我们没有发现针对个人的干预措施有有益或有害影响的证据。各种干预措施和结局的证据确定性从极低到中度不等。重返工作通常是研究的次要结局,因此,与重返工作相关的结果报告往往不佳。遵循RCT报告指南可以大大改善未来研究的证据。在针对工作的干预措施的对照试验、重返工作过程中的健康相关生活质量以及不良反应方面存在研究空白。